z-logo
open-access-imgOpen Access
Cost-effectiveness of Tocilizumab in Severe Coronavirus Disease 2019: to See or Not to See
Author(s) -
Lauren Pischel,
George Goshua
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab459
Subject(s) - tocilizumab , covid-19 , medicine , coronavirus , disease , virology , intensive care medicine , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom